PubRank

R M Egeler

Author PubWeight™ 70.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997 3.83
2 Alternative therapies for the treatment of childhood cancer. N Engl J Med 1998 2.82
3 HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997 2.59
4 X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995 1.65
5 Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas. Eur J Cancer 2004 1.58
6 Choroid plexus tumours. Br J Cancer 2002 1.50
7 Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients. Bone Marrow Transplant 2005 1.41
8 Langerhans cell histiocytosis--clinical and epidemiological aspects. Br J Cancer Suppl 1994 1.38
9 Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 2009 1.35
10 The epidemiology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998 1.28
11 Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995 1.24
12 Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 2010 1.20
13 Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia 2005 1.19
14 Biology of Langerhans cells and Langerhans cell histiocytosis. Int Rev Cytol 2006 1.17
15 Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol 1999 1.14
16 How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant 2005 1.11
17 Radiation therapy and survival in choroid plexus carcinoma. Lancet 1999 1.11
18 High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2009 1.09
19 Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998 1.08
20 Familial clustering of Langerhans cell histiocytosis. Br J Haematol 1999 1.06
21 Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2007 1.05
22 Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity. Bone Marrow Transplant 2005 1.02
23 Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation. Leukemia 2010 1.00
24 Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 2008 0.96
25 Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 2009 0.95
26 Treatment of Langerhans cell histiocytosis with pamidronate. J Pediatr Hematol Oncol 2001 0.95
27 Papillary meningioma with pleural metastasis: case report and literature review. Acta Neurol Scand 2000 0.92
28 Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature. Bone Marrow Transplant 2005 0.91
29 Managing a dual role--experiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children. Psychooncology 2010 0.89
30 Significance of amplified fragment length polymorphism in identification and epidemiological examination of Candida species colonization in children undergoing allogeneic stem cell transplantation. J Clin Microbiol 2004 0.89
31 ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr Blood Cancer 2007 0.88
32 Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer 1997 0.87
33 Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity. Bone Marrow Transplant 2005 0.87
34 Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus. Rheumatology (Oxford) 2004 0.85
35 Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr 1997 0.85
36 Simultaneous occurrence of viral-associated hemophagocytic syndrome and Langerhans cell histiocytosis: a case report. Pediatr Hematol Oncol 1995 0.84
37 New insights into the pathogenesis of Langerhans cell histiocytosis. Curr Opin Pediatr 1997 0.84
38 Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression. Bone Marrow Transplant 2007 0.83
39 Dexamethasone increases hepatotoxicity of MTX in children with brain tumors. Anticancer Res 1998 0.83
40 Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience. Bone Marrow Transplant 2003 0.82
41 Parental stress before, during, and after pediatric stem cell transplantation: a review article. Support Care Cancer 2009 0.81
42 Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT. Bone Marrow Transplant 2009 0.81
43 Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease. J Pathol 2007 0.80
44 Growth of children with Langerhans cell histiocytosis. Eur J Pediatr 1995 0.80
45 Langerhans cell histiocytosis and acute leukemia: unusual association in two cases. Med Pediatr Oncol 1993 0.80
46 Progress of fundamental research in Wilms' tumor. Urol Res 1997 0.79
47 Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT. Bone Marrow Transplant 2008 0.79
48 Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplant 2005 0.79
49 Survey on haematopoietic stem cell transplantation for children in Europe. Bone Marrow Transplant 2005 0.78
50 CsA exposure is associated with acute GVHD and relapse in children after SCT. Bone Marrow Transplant 2009 0.78
51 Hepatic hemangioendothelioma of infancy: treatment with interferon alpha. J Pediatr Gastroenterol Nutr 1997 0.78
52 Pediatric hematopoietic stem cell transplantation. Hematol Oncol Clin North Am 2001 0.78
53 Neuroblastoma 4S with an unfavorable biological marker: what to do? Med Pediatr Oncol 1999 0.78
54 Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor. Genes Chromosomes Cancer 2000 0.78
55 Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH). Pediatr Res 2000 0.78
56 The importance of identifying a back-up donor for unrelated stem cell transplantation. Bone Marrow Transplant 2005 0.78
57 Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre. Bone Marrow Transplant 2009 0.77
58 Neuropsychologic deficits in children with Langerhans cell histiocytosis. Med Pediatr Oncol 1999 0.77
59 Malignant histiocytic disorders in children. Clinical and therapeutic approaches with a nosologic discussion. Hematol Oncol Clin North Am 1998 0.76
60 HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI. Bone Marrow Transplant 2007 0.76
61 IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD. Bone Marrow Transplant 2011 0.76
62 Genetics of Wilms' tumor. Semin Urol Oncol 1999 0.76
63 An international histiocytic language. Blood 1995 0.75
64 Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer 1996 0.75
65 Langerhans' cell histiocytosis is caused by dysregulation of the E-cadherin-beta-catenin cascade: a hypothesis. Immunol Cell Biol 1999 0.75
66 Infallible measures needed to prevent errors in the administration of chemotherapeutic agents. Med Pediatr Oncol 1999 0.75
67 Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer 1995 0.75
68 Childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000 0.75
69 More on pamidronate in Langerhans'-cell histiocytosis. N Engl J Med 2001 0.75
70 Clonality in Langerhan's cell histiocytosis. BMJ 1995 0.75
71 [Two brothers with familial hemophagocytic lymphohistiocytosis, treated by transplantation of stem cells from a single unrelated donor]. Ned Tijdschr Geneeskd 2002 0.75
72 Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group. Bone Marrow Transplant 2011 0.75
73 [Langerhans-cell histiocytosis]. Ned Tijdschr Geneeskd 1998 0.75
74 Mesna inactivates platinum agents in vitro. Anticancer Res 1999 0.75
75 Investigational approaches to the treatment of brain tumors in children. Med Pediatr Oncol 1999 0.75
76 Patient reported outcomes in pediatric oncology practice: suggestions for future usage by parents and pediatric oncologists. Pediatr Blood Cancer 2014 0.75
77 Autologous transplantation of G-CSF mobilized bone marrow cells in a child with disseminated fibrosarcoma. Bone Marrow Transplant 1997 0.75
78 [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. Ned Tijdschr Geneeskd 2002 0.75
79 Sudden death due to pulmonary embolism as presenting symptom of renal tumors. Pediatr Blood Cancer 2008 0.75
80 Genetic and immunological parameters governing in vivo susceptibility/resistance to retrovirally induced murine malignant histiocytosis. J Leukoc Biol 1998 0.75
81 Infantile hepatic hemangioendothelioma. JBR-BTR 1999 0.75